| Schedule of purchase price considerations at acquisition date |
The following table summarizes the estimated acquisition-date fair value of consideration transferred for each acquisition: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | MediFind | | Access | | ConnectOnCall | | Total | | Cash consideration paid to sellers | | $ | 4,195 | | | $ | 6,766 | | | $ | 3,946 | | | $ | 14,907 | | | Equity consideration paid to sellers | | 4,676 | | | 30,645 | | | — | | | 35,321 | | | Liabilities incurred to sellers | | — | | | — | | | 10,000 | | | 10,000 | | | Total fair value of acquisition consideration | | $ | 8,871 | | | $ | 37,411 | | | $ | 13,946 | | | $ | 60,228 | |
The following table summarizes the calculation of cash paid for each acquisition, net of cash acquired per the Company's consolidated statement of cash flows for the fiscal year ended January 31, 2024. | | | | | | | | | | | | | | | | | | | | | | | | | MediFind | | Access | | ConnectOnCall | | Total | | Cash consideration paid to sellers | $ | 4,195 | | | $ | 6,766 | | | $ | 3,946 | | | $ | 14,907 | | | Less: cash acquired | (231) | | | (80) | | | (23) | | | (334) | | | Cash paid for acquisitions, net of cash acquired per statement of cash flows | $ | 3,964 | | | $ | 6,686 | | | $ | 3,923 | | | $ | 14,573 | |
| | | | | | | Cash consideration paid to sellers | $ | 37,112 | | | Liabilities incurred to sellers | 96 | | | Total fair value of acquisition consideration | $ | 37,208 | |
The following table summarizes the calculation of cash paid for the acquisition of Insignia, net of cash acquired per the Company's consolidated statement of cash flows for the year ended January 31, 2022. | | | | | | | Cash consideration paid to sellers | $ | 37,112 | | | Less: cash acquired | (2,689) | | | Cash paid for acquisition of Insignia, net of cash acquired per statement of cash flows | $ | 34,423 | |
|
| Schedule of allocation of purchase price of assets acquired and liabilities assumed |
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed at the date of each acquisition: | | | | | | | | | | | | | | | | | | | | | | | | | MediFind | | Access | | ConnectOnCall | | Total | | Cash | $ | 231 | | | $ | 80 | | | $ | 23 | | | $ | 334 | | | Accounts receivable | 149 | | | 1,870 | | | 244 | | | 2,263 | | | Other current assets | 722 | | | 110 | | | 33 | | | 865 | | | Identified intangible assets acquired | 2,300 | | | 18,300 | | | 2,000 | | | 22,600 | | | Goodwill | 6,821 | | | 23,426 | | | 11,862 | | | 42,109 | | | Total assets acquired | $ | 10,223 | | | $ | 43,786 | | | $ | 14,162 | | | $ | 68,171 | | | Accounts payable | (121) | | | (196) | | | (89) | | | (406) | | | Accrued liabilities | (816) | | | (884) | | | (49) | | | (1,749) | | | Deferred revenue | (292) | | | (5,295) | | | (78) | | | (5,665) | | | Deferred income tax liabilities | (123) | | | — | | | — | | | (123) | | | Total purchase price | $ | 8,871 | | | $ | 37,411 | | | $ | 13,946 | | | $ | 60,228 | |
|
| Schedule of intangible assets acquired |
The components of intangible assets acquired in the MediFind Acquisition were as follows: | | | | | | | | | | | | | Estimated Useful Life
(in Years) | | Fair Value | | Technology | 7 | | $ | 1,200 | | | Trademark | 15 | | 700 | | | Customer relationships | 10 | | 400 | | | Total identifiable intangible assets acquired | | | $ | 2,300 | |
The components of intangible assets acquired in the Access Acquisition were as follows: | | | | | | | | | | | | | Estimated Useful Life
(in Years) | | Fair Value | | Technology | 7 | | $ | 5,200 | | | Trademark | 15 | | 2,400 | | | Customer relationships | 15 | | 10,700 | | | Total identifiable intangible assets acquired | | | $ | 18,300 | |
The components of intangible assets acquired in the ConnectOnCall Acquisition were as follows: | | | | | | | | | | | | | Estimated Useful Life
(in Years) | | Fair Value | | Technology | 5 | | $ | 1,500 | | | Customer relationships | 15 | | 500 | | | Total identifiable intangible assets acquired | | | $ | 2,000 | |
|